Lv1
30 积分 2026-02-23 加入
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
21天前
已完结
Elucidating the Role of EGFRL858R in Brain Metastasis Among Patients With Advanced NSCLC Undergoing TKI Therapy
1个月前
已完结
Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer
1个月前
已完结
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial
1个月前
已完结
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study
1个月前
已完结
State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma
2个月前
已关闭